A Bay Area biotech company appears to be one major step closer to receiving final federal approval for its groundbreaking ...

Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge ...

AI is set to trigger a massive reshuffling of corporate profits, with $4.7 trillion at stake globally over the next decade.

Researchers have miniaturised a semi-perfusion clone screening method to a 96-well deepwell plate format and shown that a multi-parameter manufacturability index delivers more consistent clone ...

The Pentagon will launch "Project Meridian", a new initiative aimed at shaping the future of warfare, US defence secretary ...

XPH delivered 19% higher returns over five years despite half the volatility. XBI's 165 holdings offer broader exposure but ...

A further $173 billion a year is real on paper – but only once three separate regulatory clocks finish running down.

Morgan Stanley highlights 3 biotech breakthroughs in Alzheimer's, gene editing, and AI that could shape investor returns.

Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced data published in the Proceedings of the ...

Bio raises $48M Series A led by UPMC Enterprises & Ziff Capital to target Th17 cells via CD161+ antibody & CAD mRNA platforms ...

Oneness Biotech Co., Ltd., a Taiwan-based biotechnology company advancing innovative drugs for metabolic disorders, today ...

CEO Barry Quart described the COPD data as “overwhelming evidence of the potential benefit” of early rademikibart treatment and said the company plans to engage FDA as soon as feasible regarding a ...